Neuroepidemiology

Original Paper

Impaired Motor Speed, Visuospatial Episodic Memory and Verbal Fluency Characterize Cognition in Long-Term Stroke Survivors: The Tromsø Study

Engstad T.a · Almkvist O.b,c · Viitanen M.b,d · Arnesen E.a

Author affiliations

aInstitute of Community Medicine, University of Tromsø, Norway; bDepartment of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden; cDepartment of Psychology, University of Stockholm, Sweden; dDepartment of Geriatric Medicine, University of Tromsø, Norway and University of Turku, Finland

Related Articles for ""

Neuroepidemiology 2003;22:326–331

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: October 21, 2003
Issue release date: November – December

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 4

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED

Abstract

The cognitive function after stroke is examined in acute and subacute phase, but poorly characterized in long-term stroke survivors. This paper discusses cognitive function among long-term stroke survivors, with matched stroke-free subjects, based on a population survey. General cognition, verbal, executive and visuospatial function, memory, attention, and motor speed were tested as well as motor function in upper extremities. Stroke survivors and controls were most effectively discriminated by means of motor speed, followed by visuospatial episodic memory and verbal fluency. This pattern of cognitive disturbances may be a consequence of cerebral lesions in frontal subcortical areas, and is different from Alzheimer’s disease.

© 2003 S. Karger AG, Basel




Related Articles:


References

  1. Ebrahim S, Nouri F, Barer D: Cognitive impairment after stroke. Age Ageing 1985;14:345–350.
  2. Kotila M, Waltimo O, Niemi ML, et al: Dementia after stroke. Eur Neurol 1986;25:134–140.
  3. Leys D, Erkinjuntti T, Desmond DW, et al: Vascular dementia: The role of cerebral infarcts. Alzheimer Dis Assoc Disord 1999;13(suppl 3):38–48.
  4. Pohjasvaara T, Mantyla R, Salonen O, et al: How complex interactions of ischemic brain infarcts, white matter lesions and atrophy relate to poststroke dementia. Arch Neurol 2000;57:1295–1300.
  5. Desmond DW, Moroney JT, Sano M, et al: Recovery of cognitive functions after stroke. Stroke 1996;27:1798–1803.
  6. Henon H, Pasquier F, Durieu I, et al: Preexisting dementia in stroke patients. Baseline frequency, associated factors and outcome. Stroke 1997;28:2429–2436.
  7. Pohjasvaara T, Mantyla R, Aronen HJ, et al: Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort. J Neurol Neurosurg Psychiatry 1999;67:742–748.
  8. Kalra L, Jackson SHD, Swift CG: Neuropsychological test performance as an indicator of silent cerebrovascular disease in elderly hypertensives. Age Ageing 1994;23:517–523.
  9. Erkinjuntti T, Østbye T, Steenhuis R, et al: The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997;337:1667–1674.
  10. Desmond DW: Vascular dementia: A concept in evolution. Cerebrovasc Brain Metab Rev 1996;8:296–325.
  11. Patel MD, Coshall C, Rudd AG, et al: Cognitive impairment after stroke: Clinical determinants and its association with long-term stroke outcomes. J Am Geriatr Soc 2002;50:700–706.
  12. Hénon H, Durieu I, Guerouaou D, et al: Poststroke dementia. Incidence and relationship to prestroke cognitive decline. Neurology 2001;57:1216–1222.
  13. Stensland-Bugge E, Bønaa KH, Joakimsen O: Reproducibility of ultrasonographically determined intima-media thickness is dependent on arterial wall thickness. Stroke 1997;28:1972–1980.
  14. Engstad T, Bønaa KH, Viitanen M: Validity of self-reported stroke. The Tromsø Study. Stroke 2000;31:1602–1607.
  15. Roden JA, Britton M, Gustafsson C, et al: Validation of four scales for the acute stage of stroke. J Intern Med 1994;236:125–136.
  16. Montgomery SA, Åsberg MA: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–389.
  17. Bäckman L, Forsell Y: Episodic memory functioning in a community-based sample of very old adults with major depression: Utilisation of cognitive support. J Abnorm Psychol 1994;103:361–370.
  18. Lezak MD: Verbal functions and language skills. Neuropsychological assessment. Oxford, Oxford University Press, 1995, pp 545–546.
  19. Wechsler D: Wechsler Adult Intelligence Scale – Revised: Manual. San Antonio, Psychological Corp., 1981.
  20. Gamberale G, Iregren A, Kjellberg A: The Swedish Performance Evaluation System, SPES Version 5.0:Depressive Symptoms, Anxiety or Educational Level. Solna/SE, National Institute of Occupational Health, 1993.
  21. Folstein MF, Folstein SE, McHugh PR: ‘Mini-Mental State’: A practical method for grading cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  22. Nagelkerke NJD: A note on a general definition of the coefficient of determination. Biometrica 1978;78:691–692.
  23. SAS/STAT: User’s Guide, Version 8. Cary, SAS Institute Inc, 1999.
  24. Kertesz A, Clydesdale S: Neuropsychological deficits in vascular dementia versus Alzheimer’s disease. Arch Neurol 1994;51:1226–1231.
  25. Almkvist O, Wahlund LO, Andersson-Lundman G, et al: White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992;49:626–632.
  26. Price TR, Manolio TA, Kronmal RA, et al: Silent brain infarctions on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. Stroke 1997;28:1158–1164.
  27. Desrosiers J, Bourbonnais D, Bravo G, et al: Performance of the ‘unaffected’ upper extremity of elderly stroke patients. Stroke 1996;27:1564–1570.
  28. Cramer SC, Mark A, Barquist K, et al: Motor cortex activation is preserved in patients with chronic hemiplegic stroke. Ann Neurol 2002;52:607–616.
  29. Lindenberger U, Baltes PB: Intellectual functioning in old and very old age: Cross-sectional results from the Berlin Aging Study. Psychol Aging 1997;12:410–432.
  30. Korten AE, Henderson AS, Christensen H, et al: A prospective study of cognitive function in the elderly. Psychol Med 1997;27:919–930.
  31. Dichgans M: CADASIL: A monogenic condition causing stroke and subcortical vascular dementia. Cerebrovasc Dis 2002;13(suppl 2):37–41.
  32. Almkvist O: Neuropsychological features of early Alzheimer’s disease: Preclinical and clinical stages. Acta Neurol Scand 1996;165(suppl):63–71.
  33. Hachinski V: Vascular dementia: The need of a new approach (editorial). J Intern Med 1997;242:277–278.
  34. Larkin M: Ageing brains put both hemispheres to work on complex tasks. Lancet 2001;358:644.
  35. Lange G, Waked W, Kirshblum S, et al: Organizational strategy influence on visual memory performance after stroke: Cortical/subcortical and left/right hemisphere contrasts. Arch Phys Med Rehabil 2000;81:89–94.
  36. Kolb B, Whishaw IQ: The temporal lobes; in Kolb B, Whishaw IQ (eds): Fundamentals of Human Neuropsychology. New York, Freeman-Worth, 1996, pp 286–303.
  37. Phelps EA, Hyder F, Blamire AM, et al: Functional magnetic resonance imaging of the prefrontal cortex during overt verbal fluency. Neuroreport 1997;8:561–565.
  38. Kolb B, Whishaw IQ: The frontal lobes; in Kolb B, Whishaw IQ (eds): Fundamentals of Human Neuropsychology. New York, Freeman-Worth, 1996, pp 305–331.
  39. Almkvist O, Bäckman L, Basun H, et al: Patterns of neuropsychological performance in Alzheimer’s disease and vascular dementia. Cortex 1993;29:661–673.
  40. Cummings JL: Frontal-subcortical circuits and human behaviour. Arch Neurol 1993;50:873–880.
  41. Kwan LT, Reed BR, Eberling JL, et al: Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Arch Neurol 1999;56:809–814.
  42. Lee SC, Park SJ, Ki HK, et al: Prevalence and risk factors of silent cerebral infarction in apparently normal adults. Hypertension 2000;36:73–77.
  43. Lindgren A, Norrving B, Rudling O, et al: Comparison of clinical and neuroradiological findings in first-ever stroke. A population-based study. Stroke 1994;25:1371–1377.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: October 21, 2003
Issue release date: November – December

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 4

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP